The Food and Drug Administration (FDA) has approved a generic version of mifepristone, a medication used in hormone abortions. This approval represents a significant step in streamlining the pharmaceutical market. Mifepristone is a medication used to manage early miscarriage and pregnancy complications. The FDA granted the generic version a green light based on thorough review of manufacturing data and safety assessments. This decision allows for wider availability and potentially lower costs for patients seeking this medication.
Credits: NYT > Top Stories
